Hazel M. Aker, SVP, GC & Secretary at CADENCE PHARMACEUTICALS INC (CADX), sold 52,056 shares at $7.00 ($385K) on 2013-11-15, disclosed to the SEC on 2013-11-18.
Scheduled sale ($385k) by SVP, GC & Secretary under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.00 | 26,028 | $182K | 47.3% |
| 2 | $7.81 | 26,028 | $203K | 52.7% |
| Total | $7.41 avg | 52,056 | $385K | 100% |
| Filing → |
| CADX | SELL | 2013-07-23 | $51K | — | Filing → |
| CADX | SELL | 2013-07-17 | $48K | — | Filing → |
| CADX | SELL | 2011-11-22 | $42K | — | Filing → |